FIGURE 2.
p38 sensitises cardiomyocytes to Lp(a)-induced ferroptosis. (A) Time-dependent upregulation of phosphorylated p38 (p-p38) protein levels was observed in AC16 cells treated with 2 μmol/L Lp(a) for 0, 3, 6, 12, and 24 h. (B) Confocal microscopy revealed increased p-p38 expression in both the cytoplasm and nuclei of AC16 cells following 24-h exposure to 2 μmol/L Lp(a). (C) Pre-treatment with 10 μmol/L SB203580 for 1 h attenuated the Lp(a)-induced upregulation of p-p38 and ACSL4 expression, as well as the downregulation of GPX4 expression. (D) SB203580 pre-treatment for 1 h suppressed Lp(a)-triggered cell death. (E) SB203580 pre-treatment for 1 h reduced Lp(a)-induced elevation of FerroOrange fluorescence intensity. (F) SB203580 pre-treatment for 1 h mitigated Lp(a)-induced increases in intracellular MDA levels. (G) p38 knockdown via siRNA inhibited Lp(a)-mediated upregulation of p-p38 and ACSL4 expression, as well as the downregulation of GPX4 expression. (H) p38 knockdown via siRNA prevented Lp(a)-induced cell death. (I) p38 knockdown via siRNA attenuated Lp(a)-induced enhancement of FerroOrange fluorescence intensity. (J) p38 knockdown via siRNA attenuated Lp(a)-induced increases in intracellular MDA levels. *P < 0.01 versus the control group; #P < 0.01 versus the Lp(a) group. The values are expressed as mean ± SD (n = 6 per group).
